Titles

Professor and Parke-Davis Chair in Geriatric Pharmacotherapy

Department of Practice, Sciences, and Health Outcomes Research

Director of Research

Peter Lamy Center on Drug Therapy and Aging

School Affiliation

School of Pharmacy

Specialties

• Health Services Research in Mental Health
• Substance Use Disorders in Geriatrics

About

(410) 706-4352 lsimoniw@rx.umaryland.edu

Dr. Linda Wastila is professor and Parke-Davis Chair in Geriatric Pharmacotherapy in the Department of Practice, Sciences, and Health Outcomes Research and director of research for the Peter Lamy Center for Drug Therapy and Aging. For more than two decades, she has conducted research focusing on prescription drug policy, quality, and outcomes. She received her Bachelor of Science in Pharmacy from the University of North Carolina at Chapel Hill, where she also completed a Master of Science in Public Health. In 1993, she received her doctorate in health policy from Brandeis University, where she served as a Pew Health Policy Fellow. From 1994–2001, she served as senior scientist at the Schneider Institute for Health Policy and was a lecturer at Harvard Medical School. With a focus on older adults and other vulnerable populations, Dr. Wastila examines issues such as: prescription drug use, abuse, and diversion; intended and unintended policy impacts on prescription drug utilization and outcomes; psychopharmacological medication use, quality, and outcomes in community- and residential-residing older adults; innovative methods addressing multi-morbidity and poly-pharmacy; mental health disorders and impact on medication use, adherence, and outcomes; and medication quality and falls prevention. Dr. Wastila’s current research portfolio includes papers on psychopharmacological treatment and quality of treatment in long-term care beneficiaries, substance use disorders epidemiology, and co-morbidity of psychiatric and physical health conditions. She has received grants and contracts from the National Institute of Aging, National Institute on Drug Abuse, the Substance Abuse and Mental Health Services Administration, the Agency for Health Research and Quality, the Centers for Medicare and Medicaid Services, the Research Retirement Foundation, the Maryland Department of Health, and other sources.

Read a longer bio.

For interview requests, please contact the Office of Communications and Public Affairs.

Tagged: The Future of Health Care   Ensuring Access and Equity in Health Care   Caring for the Human Condition   Research and Innovation  

This information was last updated January 13, 2023.